Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Client Account Access
Fixed Income Client Portal
Merchant Banking Investor Access
Research Access
Read more
about CRISPRTherapeuticsAG-2019-11-20
$315.2 Million
Image
CRISPR Therapeutics AG
Follow-On Offering
Active Bookrunner
Read more
about NextCureInc-2019-11-14
$172.3 Million
Image
NextCure, Inc.
Follow-On Offering
Active Bookrunner
Read more
about NateraInc-2019-10-16
$230.0 Million
Image
Natera, Inc.
Follow-On Offering
Active Bookrunner
Read more
about DecipheraPharmaceuticalsInc-2019-08-19
$460.0 Million
Image
Deciphera Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
Read more
about BiohavenPharmaceuticalHoldingCompanyLtd-2019-06-18
$322.6 Million
Image
Biohaven Pharmaceutical Holding Company Ltd.
Follow-On Offering
Active Bookrunner
Read more
about OncoCyteCorporation-2019-02-07
$40.3 Million
Image
OncoCyte Corporation
Follow-On Offering
Left Bookrunner
Read more
about BenefitfocusInc-2019-03-05
$275.3 Million
Image
Benefitfocus, Inc.
Follow-On Offering
Co-Manager
Read more
about ASLANPharmaceuticalsPteLtd-2021-03-02
$69.0 Million
Image
ASLAN Pharmaceuticals Pte. Ltd.
Follow-On Offering
Active Bookrunner
Read more
about NateraInc-2019-04-17
$115.0 Million
Image
Natera, Inc.
Follow-On Offering
Left Bookrunner
Read more
about BiohavenPharmaceuticalHoldingCompanyLtd-2018-12-12
$125.0 Million
Image
Biohaven Pharmaceutical Holding Company Ltd.
Follow-On Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 52
Next page
››
Subscribe to Equity Capital Markets
